Adelheim R. 1921. Classification of gases according to the pathology produced in the lung. Zentralblatt fur Pathologie 25:261. [In German]
Adler FH, Fry WE, Leopold IH. 1947. Pathologic study of ocular lesions due to Lewisite (b-chlorovinyldichloroarsine). Archives of Ophthalmology 38:89-108.
Adley FE, Uhle RJ. 1969. Protection factors and self-contained compressed-air breathing apparatus. American International Hygiene Association Journal 30:355-359.
Agency for Toxic Substances and Disease Registry. 1991. Draft. Toxicological Profile of Mustard "Gas." Washington, DC: U.S. Department of Health and Human Services.
Aitken RS. 1943. Effects of accidental exposure to mustard gas vapor. Lancet 2:602-603.
Akamizu H, Nambu S, Egawa H, Tokuoka S. 1981. Cytological and histological studies on atypical bronchial epithelium in mustard gas ex-workers. Haigan 21:318. [In Japanese]
Albert A. 1987. Xenobiosis: Foods, Drugs, and Poisons in the Human Body. New York: Chapman and Hall.
Albrecht GJ, Kiese M, Szinicz L, Sies H, Weger N. 1975. Problems of mustard gas poisoning: on the molecular understanding of the alkylating reaction with nitrogen mustard compounds. Wehrmedizinische Monatsschrift 19:12-14. [In German]
Alexander SF. 1947. Medical report of the Bari Harbor mustard casualties. Military Surgeon 101:1-17.
Alho J, Kauppinen T, Sundquist E. 1988. Use of exposure registration in the prevention of occupational cancer in Finland. American Journal of Industrial Medicine 13:581-592.
Allen AC. 1967. The Skin: A Clinicopathological Treatise. 2nd ed. New York: Grune and Stratton.
Alpert LK. 1958. Preliminary studies with sulfur mustard in human neoplastic diseases. Annals of the New York Academy of Sciences 68:1223-1224.
Althouse R, Huff J, Tomatis L, Wilbourn J. 1979. Chemicals and Industrial Processes Associated with Cancer in Humans. Supplement 1. Lyon: International Agency for Research on Cancer.
AMA Archives of Industrial Health. 1959. Beryllium disease and its control. Conference held at Massachusetts Institute of Technology, Sept. 30-Oct. 1, 1958. AMA Archives of Industrial Health 19.
Amagai T, Tsutsumi S, Matsumoto Y. 1981. Effects of arsenic trioxide and its antidotes on the uptake of tritium labeled leucine of mouse lymphocytes (abstract). Japanese Journal of Pharmacology 31:209P.
Amalric P, Bessou P, Farenc M. 1965. Delayed relapsing mustard gas keratitis. Bulletin des Societes d'Ophtalmologie 65:101-106. [In French]
Amantea G. 1918. On a new method of curing lesions from dichloroethyl sulfide. Giornale de Medicina Militare 66:893-896. [In Italian]
American Psychiatric Association. 1952. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1968. Diagnostic and Statistical Manual of Mental Disorders (DSM-II). 2nd ed. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1980. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd ed. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders (DSM-IIIR). 3rd ed., rev. Washington, DC: American Psychiatric Association.
American Psychiatric Association, Task Force on DSM-IV. Draft publication. DSM-IV Options Book: Work in Progress 9/1/91.
Ancel P. 1946. Experimental research on spina bifida. Archives d'Anatomie Microscopique et de Morphologie Experimentale 36:45-68. [In French]
Anders MW. 1988. Glutathione-dependent toxicity: biosynthesis and bioactivation of cytotoxic S-conjugates. ISI Atlas of Science: Pharmacology 2:99-104.